BNP Paribas Financial Markets
IRON icon

BNP Paribas Financial Markets’s Disc Medicine IRON Stock Holding History

BNP Paribas Financial Markets’s Portfolio IRON Stock Details IRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13.5M Buy
184,695
+56,958
+45% +$3.91M ﹤0.01% 1470
2026
Q1 		$8.17M Buy
127,737
+5,584
+5% +$388K ﹤0.01% 1685
2025
Q4 		$9.7M Buy
122,153
+84,543
+225% +$7.14M ﹤0.01% 1636
2025
Q3 		$2.49M Buy
37,610
+32,907
+700% +$1.96M ﹤0.01% 2464
2025
Q2 		$249K Sell
4,703
-5,583
-54% -$262K ﹤0.01% 3691
2025
Q1 		$511K Buy
10,286
+5,172
+101% +$288K ﹤0.01% 3173
2024
Q4 		$324K Buy
+5,114
New +$296K ﹤0.01% 3578

Other funds holding IRON

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

BNP Paribas Financial Markets's IRON Position: Q2 2026 in Review

BNP Paribas Financial Markets increased its Disc Medicine (IRON) stake by 45% in Q2 2026, buying an estimated $3.91M and bringing the position to 184,695 shares worth $13.5M. The position accounts for ﹤0.01% of the portfolio, ranked #1470.

BNP Paribas Financial Markets first reported a position in IRON in Q4 2024 and has held it in 7 quarters since. 197 funds tracked by Wall St. Rank hold IRON as of Q2 2026.

  • BNP Paribas Financial Markets held 184,695 shares of Disc Medicine worth $13.5M as of Q2 2026.
  • BNP Paribas Financial Markets bought 56,958 Disc Medicine shares in Q2 2026, an estimated $3.91M.
  • Disc Medicine made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #1470 holding.
  • BNP Paribas Financial Markets first reported a position in Disc Medicine in Q4 2024 and has held it in 7 quarters since.
  • 197 funds tracked by Wall St. Rank held Disc Medicine as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.